Inoue Izumi, Yoshimura Noriko, Iidaka Toshiko, Horii Chiaki, Muraki Shigeyuki, Oka Hiroyuki, Kawaguchi Hiroshi, Akune Toru, Maekita Takao, Mure Kanae, Nakamura Kozo, Tanaka Sakae, Mochida Satoshi, Ichinose Masao
Health Service Center, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato-Ku, Tokyo, 108-8477, Japan.
Department of Prevention Medicine for Locomotive Organ Disorders, 22, Century Medical and Research Center, The University of Tokyo, Tokyo, 113-8655, Japan.
Calcif Tissue Int. 2025 Jan 3;116(1):16. doi: 10.1007/s00223-024-01310-4.
We evaluated the role of Helicobacter pylori (H. pylori)-related chronic gastritis in the development of osteoporosis in a population-based study. A total of 1690 subjects in the cohort of the Research on Osteoarthritis/ osteoporosis Against Disability (ROAD) were investigated, and the association between gastritis and osteoporosis was evaluated by the presence of serologically assessed H. pylori-related chronic gastritis and its stage, based on H. pylori antibody titer and pepsinogen. The presence of the gastritis was associated with significantly lower bone mineral density (BMD) assessed by dual-energy x-ray absorptiometry and a significant risk of lower BMD was observed in femoral neck (adjusted odds ratio [OR]: 0.78, 95% confidence interval [CI]: 061-0.99). The progression of the gastritis appeared to further increase the risk. In the stage of non-atrophic gastritis, the risk of lower BMD was significantly high, especially in a subgroup with higher gastritis activity in the femoral neck (adjusted OR: 0.61, 95% CI: 0.42-0.89). Meanwhile, in the stage of atrophic gastritis, the highest and significant risk of lower BMD was observed in a subgroup with the most extensive and severe atrophy in femoral neck (adjusted OR: 0.62, 95% CI: 0.42-0.91). These results suggest that H. pylori-related chronic gastritis is involved in the risk of osteoporosis, with higher activity of gastritis and more extensive atrophy leading to further increased risk. The serologically assessed stage of the gastritis could be used to identify a high-risk group for osteoporosis in H. pylori-infected subjects from general population.
在一项基于人群的研究中,我们评估了幽门螺杆菌(H. pylori)相关性慢性胃炎在骨质疏松症发生发展中的作用。对骨关节炎/骨质疏松症抗残疾研究(ROAD)队列中的1690名受试者进行了调查,并根据幽门螺杆菌抗体滴度和胃蛋白酶原,通过血清学评估的幽门螺杆菌相关性慢性胃炎及其阶段来评估胃炎与骨质疏松症之间的关联。胃炎的存在与双能X线吸收法评估的骨矿物质密度(BMD)显著降低相关,并且在股骨颈观察到BMD降低的显著风险(调整优势比[OR]:0.78,95%置信区间[CI]:0.61 - 0.99)。胃炎的进展似乎会进一步增加风险。在非萎缩性胃炎阶段,BMD降低的风险显著较高,尤其是在股骨颈胃炎活动度较高的亚组中(调整OR:0.61,95% CI:0.42 - 0.89)。同时,在萎缩性胃炎阶段,在股骨颈萎缩最广泛和严重的亚组中观察到BMD降低的最高且显著风险(调整OR:0.62,95% CI:0.42 - 0.91)。这些结果表明,幽门螺杆菌相关性慢性胃炎与骨质疏松症风险有关,胃炎活动度越高和萎缩越广泛会导致风险进一步增加。血清学评估的胃炎阶段可用于识别来自普通人群的幽门螺杆菌感染受试者中的骨质疏松症高危人群。